Pharmaceutical Supply Chain & Distribution Center Contingencies During COVID-19:
Collaborative Learning Q&A

Listen to a Q&A with Patrick Girten Manager, Quality Distribution US/PR, Bristol Myers Squibb, & Michael Hollweck, Senior Manager QA Logistics Americas, Celgene about how their supply chains were affected by COVID-19, including:

• Precautionary DC operations during COVID
• Creating redundancy in distribution with secondary sites and logistics providers
• Approving new contingency routes
• Shipping cross borders and customs
• Virtual audits—is this a viable future for pharmaceutical QA supply chains?